European Neuropsychopharmacology Archives

Study: Cannabinoids a Potential Treatment for Disorders Associated with Traumatic Memories

May 1, 2017May 1, 2017 by Anthony Martinelli

Cannabinoids provide a potential treatment option for disorders associated with traumatic memories, according to a new study.

The study was published in the journal European Neuropsychopharmacology, and e-published ahead of print by the U.S. National Institute of Health.

“Memory reconsolidation is the process in which reactivated long-term memory becomes transiently sensitive to amnesic agents”, states the study’s abstract. “We evaluated the ability of post reactivation administration of the mTOR inhibitor rapamycin, separately and in combination with the cannabinoid CB1/2 receptor agonist WIN55,212-2 (WIN) [meant to mimic the effects of natural cannabinoids]”. This was given “systemically or specifically into the hippocampal CA1 area, basolateral amygdala (BLA) or insular cortex (IC), to reduce inhibitory avoidance fear in rats.”

Study: Cannabinoids a Treatment Option for Diabetes-Associated Depression

August 22, 2016 by Anthony Martinelli

The journal European Neuropsychopharmacology has published a study showing that cannabinoids may provide a treatment option for depression associated with diabetes.

“The pathophysiology associated with increased prevalence of depression in diabetics is not completely understood, although studies have pointed the endocannabinoid system as a possible target”, researchers state. With this in mind, they “aimed to investigate the role of this system in the pathophysiology of depression associated with diabetes.”